All
Allergan's Botox not involved in Fla. poisonings
January 1st 2005National report - California pharmaceutical manufacturer Allergan is taking steps to reassure doctors and patients about the safety of Botox after four people became critically ill after they were treated with an unapproved raw botulinum toxin.
FDA approves world's first implantable ID chip for humans
January 1st 2005National report - The U.S. Food and Drug Administration's recent approval for medical applications of VeriChip, the world's first implantable identification device for humans, could signal the beginning of a new state-of-the-art world of computerized data tracking previously seen only in science fiction movies.
Face transplants: Moving forward?
January 1st 2005Cleveland - Facial transplantation, a controversialprocedure, has moved one step closer to clinical practice,following approval of a protocol late last year by the ClevelandClinic's internal review board. However, no one can say when thefirst facial transplant will take place.
Alternative treatments:Doctors urge caution in gauging effectiveness
December 1st 2004National report - When it comes to dermatologic treatments that fall outside the mainstream, patients have long found plenty of these on their own. What they don't always find is help in evaluating these treatments' effectiveness.
Alternative treatments:Doctors urge caution in gauging effectiveness
December 1st 2004National report - When it comes to dermatologic treatments that fall outside the mainstream, patients have long found plenty of these on their own. What they don't always find is help in evaluating these treatments' effectiveness.
Sophisticated planning provides protection and profits
December 1st 2004Philadelphia - Dermatologists who set aside a few hours per year to meet with a qualified advisor to discuss asset protection, income tax reduction and estate planning will reap many business and personal financial rewards, according to David B. Mandell, J.D., M.B.A. and Lawrence B. Keller, C.L.U., Ch.F.C., R.H.U., L.U.T.C.F.
ICD-9-CM, CPT, conversion factor changes for 2005
December 1st 2004Many reliable sources will be providing physicians and staff input regarding all the changes set forth by the American Medical Association (AMA) and the Center for Medicare & Medicaid Services (CMS) for fiscal year 2005. Based on the display copy of the Nov. 2, 2004 Federal Register, the 2005 AMA CPT book, and the ICD-9-CM Book for 2005 published by the World Health Organization, pertinent changes for dermatology practices are summarized below:
New AK therapies offer tx choices
December 1st 2004National Report - With the rapid onset of new therapies available for the treatment of actinic keratosis (AK), Stacy Smith, M.D. of Therapeutics Clinical Research in California, has demonstrated that efficacy, tolerability and cost play a combined role in the approach used to treat AK.
New AK therapies offer tx choices
December 1st 2004National Report - With the rapid onset of new therapies available for the treatment of actinic keratosis (AK), Stacy Smith, M.D. of Therapeutics Clinical Research in California, has demonstrated that efficacy, tolerability and cost play a combined role in the approach used to treat AK.
Community-acquired MRSA leaps upward among children
December 1st 2004National report - The number of cases of community-acquired methicillin-resistant Staphylococcus aureus (CAMRSA) among healthy American children has risen exponentially over the past few years, and resistant strains of S. aureus appear to be more virulent than non-resistant strains.
NMSC requires more aggressive screening, treatment, doctor says
November 1st 2004Zurich - Although data on the incidence and prevalence of non-melanoma skin cancer (NMSC) remain limited, Dr. Rolf-Markus Szeimies of the department of dermatology, University of Regensburg Hospital, Germany, has compiled epidemiologic data demonstrating an increased incidence of actinic keratosis (AK), squamous cell carcinoma (SCC) and basal cell carcinoma (BCC).
Targeting inflammatory mediators in acne
November 1st 2004New York - With an increased understanding of the inflammatory response in acne, Diane Thiboutot, M.D., Pennsylvania State University College of Medicine, has reviewed data demonstrating the role of the toll-like 2 receptors in inflammatory acne as well as the effect of retinoids in targeting inflammatory mediators.